Affiliation:
1. Department of General Practice, The Third Affiliated Hospital of Sun Yat-Sen University Lingnan Hospital, Guangzhou, Guangdong Province, People’s Republic of China.
Abstract
Microbiological identification is essential for appropriate treatment, but conventional methods are time-consuming and have a low sensitivity. In contrast, metagenomic next-generation sequencing (mNGS) is a culture-free and hypothesis-free technique that can detect a wide array of potential pathogens. This study aimed to reveal the overall diagnostic value of mNGS for infectious diseases of different organ systems and compare the sensitivity and specificity of mNGS with conventional methods. In a retrospective cohort study, 94 patients with mNGS results were enrolled, and clinical data were recorded and analyzed to compare the positive rate of mNGS with traditional methods including as smears, serological tests, and traditional PCR, etc. In this study, mNGS and culture were both positive in 12.77% cases and were both negative in 23.4% cases. There were positive results in 56 cases (54.26%) only by mNGS and 4 cases (4.26%) were positive only by culture. There were significant differences in sensitivity of pathogen detection between of ID and NID group for mNGS (χ2 = 10.461, P = .001)and conventional methods(χ2 = 7.963, P = .005). The positive predictive values and negative predictive values of diagnosing infectious disease by mNGS were 94.12% and 30.77%, respectively. mNGS increased the sensitivity rate by approximately 53.66% compared with that of culture (78.05% vs24.39%; χ2 = 47.248, P < .001) and decreased the specificity rate by 12.5% compared with that of culture (66.67% vs 100.0%; χ2 = 4.8, P = .028). mNGS can identify emerging or rare pathogen and further guide treatment regimens. mNGS has advantages in identifying overall pathogens and bacteria, however, there was no obvious advantage in identifying fungi, virus and tuberculosis. mNGS has higher specificity than conventional methods in identifying pathogens and advantages in detecting emerging or rare pathogens.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference30 articles.
1. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.;Lozano;Lancet,2012
2. Use of whole-genome sequencing to trace, control and characterize the regional expansion of extended-spectrum beta-lactamase producing ST15 Klebsiella pneumoniae.;Zhou;Sci Rep,2016
3. DNA sequence analysis of BlaVEB gene encoding multi-drug resistant and extended-spectrum β-lactamases producer isolates of enterobacteriaceae and pseudomonas aeruginosa.;Al-Ouqaili;Open Microbiol J,2019
4. Depending on HPLC and PCR, detection of aflatoxin B1 extracted from Aspergillus flavus strains and it’s cytotoxic effect on AFB treated-hematopoietic stem cells obtained from human umbilical cord.;Al-Ouqaili;Asian J Pharmac,2018
5. The diagnosis of infectious diseases by whole genome next generation sequencing: a new era is opening.;Lecuit;Front Cell Infect Microbiol,2014